Literature DB >> 23662697

A literature review and meta-analysis of drug company-funded mental health websites.

J Read1, A Cain.   

Abstract

OBJECTIVE: The pharmaceutical industry exercises pervasive influence in the mental health field. The internet has become a primary source of mental health information for the public and practitioners. This study therefore compared mental health websites funded and not funded by drug companies.
METHOD: A systematic literature review of studies examining the role of drug companies in the funding of mental health websites was conducted, followed by a meta-analysis of studies comparing drug company-funded (DCF) sites with sites not funded by the industry.
RESULTS: Mental health websites, in general, overemphasize biogenetic causal explanations and medication. Many mental health websites (42%) are either drug company owned (6%) or receive funding from drug companies (36%). A meta-analysis found that DCF sites are significantly more biased toward biogenetic causes (P < 0.01) and toward medication (P < 0.0001) than sites that are financially independent of the industry.
CONCLUSION: Practitioners are encouraged to inform patients about the bias inherent in industry-sponsored websites and to recommend, instead, more balanced websites that present a range of evidence-based information about causes and treatments.
© 2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  drug industry; internet; mental health; psychiatry

Mesh:

Year:  2013        PMID: 23662697     DOI: 10.1111/acps.12146

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  9 in total

1.  Examining Physician Interactions with Disease Advocacy Organizations.

Authors:  Caroline Horrow; Joel E Pacyna; Carol Cosenza; Richard R Sharp
Journal:  AJOB Empir Bioeth       Date:  2019-08-26

2.  Exploring Continuum and Categorical Conceptualisations of Mental Health and Mental Illness on Australian Websites: A Systematic Review and Content Analysis.

Authors:  Dominic K Fernandez; Saniya Singh; Frank P Deane; Stewart A Vella
Journal:  Community Ment Health J       Date:  2022-08-22

3.  A survey of UK general practitioners about depression, antidepressants and withdrawal: implementing the 2019 Public Health England report.

Authors:  John Read; Julia Renton; Christopher Harrop; Jim Geekie; Christopher Dowrick
Journal:  Ther Adv Psychopharmacol       Date:  2020-08-27

4.  The Quality of Internet Websites for People Experiencing Psychosis: Pilot Expert Assessment.

Authors:  Kay Wilhelm; Tonelle Handley; Catherine McHugh; David Lowenstein; Kristy Arrold
Journal:  JMIR Form Res       Date:  2022-04-15

5.  Understanding the non-pharmacological correlates of self-reported efficacy of antidepressants.

Authors:  J Read; K Gibson; C Cartwright; C Shiels; C Dowrick; M Gabbay
Journal:  Acta Psychiatr Scand       Date:  2015-01-09       Impact factor: 6.392

6.  Use of the Internet and Mobile Phones for Self-Management of Severe Mental Health Problems: Qualitative Study of Staff Views.

Authors:  Natalie Berry; Sandra Bucci; Fiona Lobban
Journal:  JMIR Ment Health       Date:  2017-11-01

7.  The role of Facebook groups in the management and raising of awareness of antidepressant withdrawal: is social media filling the void left by health services?

Authors:  Edward White; John Read; Sherry Julo
Journal:  Ther Adv Psychopharmacol       Date:  2021-01-17

8.  Understanding and responding to remote mental health help-seeking by gay, bisexual and other men who have sex with men (GBMSM) in the U.K. and Republic of Ireland: a mixed-method study conducted in the context of COVID-19.

Authors:  Dimitra Eleftheria Strongylou; Paul Flowers; Ruth McKenna; Ross Andrew Kincaid; Dan Clutterbuck; Mohamed Ahmed Hammoud; Julian Heng; Yvonne Kerr; Lisa McDaid; Jamie Scott Frankis
Journal:  Health Psychol Behav Med       Date:  2022-04-05

9.  Presentation of benefits and harms of antidepressants on websites: A cross-sectional study.

Authors:  Maryanne Demasi; Peter C Gøtzsche
Journal:  Int J Risk Saf Med       Date:  2020
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.